The potential for CETP inhibition to reduce cardiovascular disease risk-Reference-Cited by-同舟云学术

The potential for CETP inhibition to reduce cardiovascular disease risk

Published:2006-11-02 Issue:12 Volume:22 Page:2467-2478
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Ansell Benjamin¹,Richard Hobbs F. D.²

Affiliation:

1. Divisions of General Internal Medicine/Health Services Research and Cardiology, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA

2. Primary Care Clinical Sciences Building, University of Birmingham, Birmingham B15 2TT, UK

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079906X148634

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) Inhibitor;ACS Medicinal Chemistry Letters;2019-05-06

2. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice;Cardiovascular Diabetology;2014-11-13

3. Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein;ACS Medicinal Chemistry Letters;2011-03-31

4. Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community;Circulation;2009-12-15

5. Editorial [ Cardiovascular Risk Factor Modification: A sine qua non in the Management of Vascular Surgery Patients ];Current Vascular Pharmacology;2008-07-01